Related references
Note: Only part of the references are listed.Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer
Vivek Subbiah et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
JAK inhibitors to suppress paclitaxel-resistant anaplastic thyroid cancer via IL-6 reduction
Tomoyuki Fujita et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Lenvatinib for Anaplastic Thyroid Cancer and Lenvatinib-Induced Thyroid Dysfunction
Satoshi Koyama et al.
EUROPEAN THYROID JOURNAL (2018)
Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base
Todd A. Pezzi et al.
CANCER (2017)
Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model
Xuguang Zhu et al.
CLINICAL CANCER RESEARCH (2017)
Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells
Kirk Jensen et al.
ENDOCRINE-RELATED CANCER (2017)
CD70 and PD-L1 in anaplastic thyroid cancer-promising targets for immunotherapy
Karen Zwaenepoel et al.
HISTOPATHOLOGY (2017)
Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis
Silvia Cantara et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study
Ashish V. Chintakuntlawar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid Cancer
Revathi Kollipara et al.
ONCOLOGIST (2017)
Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma
Kathrin A. Schmohl et al.
THYROID (2017)
Doxorubicin has a synergistic cytotoxicity with cucurbitacin B in anaplastic thyroid carcinoma cells
Si Hyoung Kim et al.
TUMOR BIOLOGY (2017)
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Leveraging the immune system to treat advanced thyroid cancers
Jena D. French et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model
Liya Zhu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Targeted Therapy in Thyroid Cancer: State of the Art
L. Valerio et al.
CLINICAL ONCOLOGY (2017)
The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma
Carmela Passaro et al.
ONCOTARGET (2016)
Generation of Novel Thyroid Cancer Stem-Like Cell Clones Effects of Resveratrol and Valproic Acid
Heather Hardin et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Lenvatinib: Role in thyroid cancer and other solid tumors
Maria E. Cabanillas et al.
CANCER TREATMENT REVIEWS (2016)
Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC)
Junaid Abdulghani et al.
CLINICAL CANCER RESEARCH (2016)
1,25 dihydroxyvitamin D3 inhibits the proliferation of thyroid cancer stem-like cells via cell cycle arrest
Wen Peng et al.
ENDOCRINE RESEARCH (2016)
MCM5 as a target of BET inhibitors in thyroid cancer cells
Catia Mio et al.
ENDOCRINE-RELATED CANCER (2016)
Treatment of advanced thyroid cancer with targeted therapies: ten years of experience
David Viola et al.
ENDOCRINE-RELATED CANCER (2016)
The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: A systematic review and meta-analysis
Jeanny Kwon et al.
EUROPEAN JOURNAL OF CANCER (2016)
Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival
Scott M. Glaser et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer
Jill J. Bastman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Biologic and Clinical Perspectives on Thyroid Cancer
James A. Fagin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells
Lorenzo Allegri et al.
ONCOLOGY REPORTS (2016)
Novel HSP90 inhibitors effectively target functions of thyroid cancer stem cell preventing migration and invasion
Peter T. White et al.
SURGERY (2016)
Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial
Maria Graziella Catalano et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2016)
Selective use of sorafenib in the treatment of thyroid cancer
Fabian Pitoia et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosis
Devora Champa et al.
ONCOTARGET (2016)
Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer
Eran Brauner et al.
ONCOTARGET (2016)
The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells
Si Hyoung Kim et al.
ENDOCRINE (2016)
Individualized multimodal treatment strategy for anaplastic thyroid carcinoma Case report of long-term remission and review of literature
S. Eckhardt et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2016)
CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation
Poupak Fallahi et al.
ENDOCRINE (2016)
Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer
Min Zhou et al.
BIOMATERIALS (2015)
Radioactive 125I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway
Yunhong Tian et al.
BMC CANCER (2015)
MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential
Kun-Chun Chiang et al.
CANCER LETTERS (2015)
Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer
Amit Mehta et al.
CLINICAL CANCER RESEARCH (2015)
Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer
Amit Mehta et al.
ENDOCRINE-RELATED CANCER (2015)
Differential effects of MAPK pathway inhibitors on migration and invasiveness of BRAFV600E mutant thyroid cancer cells in 2D and 3D culture
Camilla Ingeson-Carlsson et al.
EXPERIMENTAL CELL RESEARCH (2015)
Novel Heat Shock Protein 90 Inhibitor NVP-AUY922 Synergizes With the Histone Deacetylase Inhibitor PXD101 in Induction of Death of Anaplastic Thyroid Carcinoma Cells
Si Hyoung Kim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
A Novel Dual AMPK Activator/mTOR Inhibitor Inhibits Thyroid Cancer Cell Growth
Robert L. Plews et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target
Christina A. von Roemeling et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Deregulation of EGFR/PI3K and activation of PTEN by photodynamic therapy combined with carboplatin in human anaplastic thyroid cancer cells and xenograft tumors in nude mice
Raktim Biswas et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2015)
Anaplastic Thyroid Carcinoma, Version 2.2015
Robert I. Haddad et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Lenvatinib and radioiodine-refractory thyroid cancers
Lara Dunn et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Trametinib with and without pazopanib has potent preclinical activity in thyroid cancer
Douglas W. Ball et al.
ONCOLOGY REPORTS (2015)
Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line
Federica Baldan et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis
Samira M. Sadowski et al.
ONCOTARGET (2015)
PARP inhibitor olaparib increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma
Carmela Passaro et al.
MOLECULAR ONCOLOGY (2015)
Tyrosine kinase inhibitors for the therapy of anaplastic thyroid cancer
Alessandro Antonelli et al.
INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY (2015)
Hesperetin Activates the Notch1 Signaling Cascade, Causes Apoptosis, and Induces Cellular Differentiation in Anaplastic Thyroid Cancer
Priyesh N. Patel et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Is Poorly Differentiated Thyroid Cancer Poorly Characterized?
Kenneth D. Burman
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Role of Salvage Targeted Therapy in Differentiated Thyroid Cancer Patients Who Failed First-Line Sorafenib
Ramona Dadu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth
Eric Weinlander et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer
Nikhil Wagle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Randomized Safety and Efficacy Study of Fosbretabulin with Paclitaxel/Carboplatin Against Anaplastic Thyroid Carcinoma
Julie A. Sosa et al.
THYROID (2014)
A New Aurora in Anaplastic Thyroid Cancer Therapy
Enke Baldini et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer
Moira Ragazzi et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Blocks to thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways
V. Gunda et al.
CELL DEATH & DISEASE (2014)
A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes
S. M. Lim et al.
ANNALS OF ONCOLOGY (2013)
Valproic Acid Sensitizes TRAIL-Resistant Anaplastic Thyroid Carcinoma Cells to Apoptotic Cell Death
Hyun-Young Cha et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo
Xiao-Min Yu et al.
CANCER (2013)
Aurora A kinase (AURKA) in normal and pathological cell division
Anna S. Nikonova et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells
Carmela Passaro et al.
ENDOCRINE-RELATED CANCER (2013)
Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial
R. C. Smallridge et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
Marina N. Nikiforova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Resveratrol Induces Differentiation Markers Expression in Anaplastic Thyroid Carcinoma via Activation of Notch1 Signaling and Suppresses Cell Growth
Xiao-Min Yu et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Alan L. Ho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression
Mabel Ryder et al.
PLOS ONE (2013)
Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer
Crescent R. Isham et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Histone Deacetylase Inhibition Affects Sodium Iodide Symporter Expression and Induces 131I Cytotoxicity in Anaplastic Thyroid Cancer Cells
Mariateresa Pugliese et al.
THYROID (2013)
The PLK1 Inhibitor GSK461364A Is Effective in Poorly Differentiated and Anaplastic Thyroid Carcinoma Cells, Independent of the Nature of Their Driver Mutations
Marika A. Russo et al.
THYROID (2013)
New Targeted Therapies for Anaplastic Thyroid Cancer
Alessandro Antonelli et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Late Intervention with anti-BRAFV600E Therapy Induces Tumor Regression in an Orthotopic Mouse Model of Human Anaplastic Thyroid Cancer
Matthew A. Nehs et al.
ENDOCRINOLOGY (2012)
Glycolytic Inhibition Alters Anaplastic Thyroid Carcinoma Tumor Metabolism and Improves Response to Conventional Chemotherapy and Radiation
Vlad C. Sandulache et al.
MOLECULAR CANCER THERAPEUTICS (2012)
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Robert C. Smallridge et al.
THYROID (2012)
Combined inhibition of cellular pathways as a future therapeutic option in fatal anaplastic thyroid cancer
Annette Wunderlich et al.
ENDOCRINE (2012)
Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer
Annette Wunderlich et al.
CANCER SCIENCE (2011)
Tumor-Associated Macrophages (TAMs) Form an Interconnected Cellular Supportive Network in Anaplastic Thyroid Carcinoma
Bernard Caillou et al.
PLOS ONE (2011)
Managing anaplastic thyroid carcinoma
Ejigayehu G. Abate et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2011)
Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model
Yong Jin Lee et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Induction of Thyroid Gene Expression and Radioiodine Uptake in Thyroid Cancer Cells by Targeting Major Signaling Pathways
Peng Hou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation
E. Borbone et al.
ONCOGENE (2010)
Anaplastic thyroid carcinoma: Expression profile of targets for therapy offers new insights for disease treatment
Sam M. Wiseman et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Anaplastic thyroid carcinoma: A 50-year experience at a single institution
B McIver et al.
SURGERY (2001)
Share Paper
